Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in Canada. It is testing methylphenidate Hydrochloride Controlled Release Capsules for ADHD.
In HamiltonThis study is completed in the United States and in Israel. It is testing MG01CI 1400 mg Compared With Placebo for ADHD.
Multiple locations, including GainesvilleThis study has public registry information in Global. It is testing Safety and Efficacy of Methylphenidate HCl ERCT for ADHD.
In GlobalThis study has public registry information in Global. It is testing Safety and Efficacy of Quillichew ERCT for ADHD.
In Global
This study is completed. It focuses on ADHD and currently lists study information in Turkey.
In BursaThis study is completed in the United States. It is testing time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) for ADHD.
Multiple locations, including Little RockThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In Santa MonicaThis study is enrolling by invitation in Sweden. It focuses on ADHD.
In GothenburgThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In CharlottesvilleThis study is completed. It focuses on ADHD and currently lists study information in Denmark.
In RisskovThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In BostonThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In Bethesda